Penicillin G potassium (Benzylpenicillin potassium)
(Synonyms: 青霉素钾; Benzylpenicillin potassium) 目录号 : GC30779A β-lactam antibiotic
Cas No.:113-98-4
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Penicillin G is a β-lactam antibiotic that is effective mainly for Gram-positive bacteria.1 It has MIC90 values of 0.03, 1, and 4 ?g/ml for penicillin-susceptible, -intermediate, and -resistant strains of S. pneumoniae, respectively, and 16-128 ?g/ml for various Bacteroides isolates in a broth dilution assay.2,3 Formulations containing penicillin G have been used for the treatment of bacterial infections and in livestock production.
1.Demain, A.L.Production of beta-lactam antibiotics and its regulationProc. Natl. Sci. Counc. Repub. China B.15(4)251-265(1991) 2.Pankuch, G.A., Lichtenberger, C., Jacobs, M.R., et al.Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologiesAntimicrob. Agents Chemother.40(7)1653-1656(1996) 3.Aldridge, K.E., Sanders, C.V., Janney, A., et al.Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides speciesAntimicrob. Agents Chemother.26(3)410-413(1984)
Cas No. | 113-98-4 | SDF | |
别名 | 青霉素钾; Benzylpenicillin potassium | ||
Canonical SMILES | O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(CC3=CC=CC=C3)=O)N1C2=O)[O-].[K+] | ||
分子式 | C16H17KN2O4S | 分子量 | 372.48 |
溶解度 | Water : ≥ 48 mg/mL (128.87 mM) | 储存条件 | Store at 2-8°C,unstable in solution, ready to use. |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.6847 mL | 13.4235 mL | 26.8471 mL |
5 mM | 0.5369 mL | 2.6847 mL | 5.3694 mL |
10 mM | 0.2685 mL | 1.3424 mL | 2.6847 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Penicillin G
Hyperkalaemia. Benzylpenicillin potassium
Degradation of Penicillin G by heat activated persulfate in aqueous solution
We used Heat Activated of Persulfate (HAP) to decompose Penicillin G (PEN G) in aqueous solution. The effect of pH (3-11), temperature (313-353 K), and initial concentration of Sodium Persulfate (SPS) (0.05-0.5 mM) on the decomposition level of PEN G were investigated. The residue of PEN G was determined by spectrophotometry at the wavelength of 290 nm. Also, the Chemical Oxygen Demand (COD) was measured in each experiment. The Total Organic Carbon (TOC) analysis was utilized for surveying the mineralization of PEN G. In addition, based on Arrhenius equation, the activation energy of PEN G decomposition was calculated. The results indicated that the maximum PEN G removal rate was obtained at pH 5 and by increasing the doses of SPS from 0.05 to 0.5 mM, the PEN G decomposition was enhanced. It was found that an increase in temperature is accompanied by an increase in removal efficiency of PEN G. The activation energy of the studied process was determined to be 94.8 kJ mol-1, suggesting that a moderate activation energy is required for PEN G decomposition. The TOC measurements indicate that the HAP can efficiently mineralize PEN G. Besides, the presence of the scavengers significantly suppressed the HAP process to remove the PEN G. Overall, the results of this study demonstrate that using HAP process can be a suitable method for decomposing of PEN G in aqueous solutions.
Identification of Penicillin G Metabolites under Various Environmental Conditions Using UHPLC-MS/MS
In this work, we investigate the stability of penicillin G in various conditions including acidic, alkaline, natural acidic matrices and after treatment of citrus trees that are infected with citrus greening disease. The identification, confirmation, and quantitation of penicillin G and its various metabolites were evaluated using two UHPLC-MS/MS systems with variable capabilities (i.e., Thermo Q Exactive Orbitrap and Sciex 6500 QTrap). Our data show that under acidic and alkaline conditions, penicillin G at 100 ng/mL degrades quickly, with a determined half-life time of approximately 2 h. Penillic acid, penicilloic acid, and penilloic acid are found to be the most abundant metabolites of penicillin G. These major metabolites, along with isopenillic acid, are found when penicillin G is used for treatment of citrus greening infected trees. The findings of this study will provide insight regarding penicillin G residues in agricultural and biological applications.
Treatment of pneumococcal pneumonia: the case for penicillin G
Although widely endorsed for specific treatment of pneumococcal pneumonia, penicillin G is seldom used for this purpose in clinical practice for at least three reasons: (1) concern about penicillin-resistant Streptococcus pneumoniae (PRSP) strains; (2) the difficulty of making an early etiologic diagnosis of pneumonia; and (3) lack of a clear consensus about the optimum dosage. Continuous infusion of 20-24 million units of penicillin per day provides serum levels of 16-20 microg/mL in persons with normal renal function. These levels easily exceed the minimum inhibitory concentrations (MICs) of penicillin G against most PRSP strains (4 microg/mL), which are actually strains with reduced susceptibility to penicillin. High-dose penicillin G therapy has not been shown to be therapeutically ineffective against pneumonia due to PRSP strains. However, the extent of penicillin resistance warrants continued monitoring, because strains exhibiting extremely high-level resistance (MIC > or = 8 microg/mL) would probably respond poorly if at all. Development and use of rapid, sensitive, specific ways to diagnose pneumococcal pneumonia could extend the usefulness of penicillin G, thus postponing the emergence of resistance to other antibiotics.